Autopsy report · NCT00847678
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Cause of deathNo reason given
Life of this trial
- Registered 2 years 6 months after it had already started.
- 38 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Cryptococcal Meningitis
- Interventions
- Efungumab (Mycograb); placebo; Amphotericin B; 5 flucytosine
- Participants
- 38
- Sites
- 1
- Countries
- South Africa
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.